Agnès Guerci - Concepedia

Author

Agnès Guerci

Centre Hospitalier Régional et Universitaire de Nancy

Also Known As

Agnes Guerci, Agnès Guerci, Agnès Guerci, Guerci, Agnès

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Régional et Universitaire de Nancy Inserm Hôpital Saint-Louis Assistance Publique – Hôpitaux de Paris Institut Paoli-Calmettes

About

Agnès Guerci is an author at Centre Hospitalier Régional et Universitaire de Nancy specializing in medicine, hematology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.3K
2	Health Sciences	8	8	1.9K
3	Cell Biology	2	2	43
4	Emergency Medicine	2	2	116
5	Classical Hematology	1	1	19

Agnès Guerci

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial François‐Xavier Mahon, Delphine Réa, Joëlle Guilhot, The Lancet Oncology Hematological MalignancyOncologyChronic Myeloid LeukaemiaHematologyMyeloid Neoplasia	2010	1.5K
Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia François Guilhot, Claude Chastang, Mauricette Michallet, New England Journal of Medicine	1997	553
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience Lionel Adès, Agnès Guerci, Emmanuel Raffoux, Blood	2009	250
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM Christian Rosé, Sabine Bréchignac, D. Vassilief, Leukemia Research Chelation TherapyMedicineIron MetabolismMetronomic TherapyPharmacotherapy	2010	195
Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia Group Lionel Adès, Sylvie Chevret, Emmanuel Raffoux, Journal of Clinical Oncology	2006	166
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results Lionel Adès, Miguel Á. Sanz, Sylvie Chevret, Blood	2007	156
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial Stéphane de Botton, Sylvie Chevret, Miguel Á. Sanz, British Journal of Haematology Hematological MalignancyMedicineEuropean TrialMixed-phenotype Acute LeukemiaHematology	2000	145
Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience Charikleia Kelaïdi, Sylvie Chevret, Stéphane de Botton, Journal of Clinical Oncology	2009	120
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients Sylvain Thépot, Raphaël Itzykson, Valérie Seegers, American Journal of Hematology	2013	100
Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study Norbert Vey, André Bosly, Agnès Guerci, Journal of Clinical Oncology	2006	90

Page 1